• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流产布鲁氏菌S19和RB51疫苗株的疗效:一项系统评价和荟萃分析。

Efficacy of Brucella abortus S19 and RB51 vaccine strains: A systematic review and meta-analysis.

作者信息

de Oliveira Marina Martins, Pereira Carine Rodrigues, de Oliveira Izabela Regina Cardoso, Godfroid Jacques, Lage Andrey Pereira, Dorneles Elaine Maria Seles

机构信息

Departamento de Medicina Veterinária, Faculdade de Zootecnia e Medicina Veterinária, Universidade Federal de Lavras - UFLA, Lavras, Brazil.

Departamento de Estatística, Instituto de Ciências Exatas e Tecnológicas, Universidade Federal de Lavras - UFLA, Lavras, Brazil.

出版信息

Transbound Emerg Dis. 2022 Jul;69(4):e32-e51. doi: 10.1111/tbed.14259. Epub 2021 Aug 14.

DOI:10.1111/tbed.14259
PMID:34328699
Abstract

This systematic review and meta-analysis aimed to recalculate the efficacy of Brucella abortus S19 and RB51 vaccine strains and discuss the main variables associated with controlled trials to evaluate bovine brucellosis vaccine efficacy (VE). The most commonly used vaccine strain was S19, at a dose of 10 colony forming units (CFU), followed by RB51 at 10 CFU. The most commonly used challenge strain was B. abortus 2308, at a dose of 10 CFU, by the intraconjunctival route. Regarding the meta-analysis, trials were grouped according to the vaccine strain and dose to recalculate protection against abortion (four groups) or infection (five groups) using pooled risk ratio (RR) and VE. Regarding protection against abortion (n = 15 trials), the S19 vaccine at 10 CFU exhibited the highest protection rate (RR = 0.25, 95% confidence interval (CI) : 0.12-0.52; VE = 75.09%, 95% CI: 48.08-88.05), followed by RB51 at 10 CFU (RR = 0.31, 95% CI: 0.16-0.61; VE = 69.25%, 95% CI: 39.48-84.38). Regarding protection against infection (n = 23 trials), only two subgroups exhibited significant protection: S19 at 10 CFU (RR = 0.28, 95% CI: 0.14-0.55; VE = 72.03%, 95% CI: 57.70- 81.50) and RB51 at 10 CFU (RR = 0.43, 95% CI: 0.22-0.84; VE = 57.05%, 95% CI: 30.90-73.30). In conclusion, our results suggest that a dose of 10 CFU for S19 and 10 CFU for RB51 are the most suitable for the prevention of abortion and infection caused by B. abortus.

摘要

本系统评价和荟萃分析旨在重新计算流产布鲁氏菌S19和RB51疫苗株的效力,并讨论与评估牛布鲁氏菌病疫苗效力(VE)的对照试验相关的主要变量。最常用的疫苗株是S19,剂量为10个菌落形成单位(CFU),其次是RB51,剂量为10 CFU。最常用的攻毒株是流产布鲁氏菌2308,剂量为10 CFU,通过结膜内途径接种。关于荟萃分析,根据疫苗株和剂量对试验进行分组,使用合并风险比(RR)和VE重新计算预防流产(四组)或感染(五组)的效果。关于预防流产(n = 15项试验),10 CFU的S19疫苗显示出最高的保护率(RR = 0.25,95%置信区间(CI):0.12 - 0.52;VE = 75.09%,95% CI:48.08 - 88.05),其次是10 CFU的RB51(RR = 0.31,95% CI:0.16 - 0.61;VE = 69.25%,95% CI:39.48 - 84.38)。关于预防感染(n = 23项试验),只有两个亚组显示出显著的保护作用:10 CFU的S19(RR = 0.28,95% CI:0.14 - 0.55;VE = 72.03%,95% CI:57.70 - 81.50)和10 CFU的RB51(RR = 0.43,95% CI:0.22 - 0.84;VE = 57.05%,95% CI:30.9

相似文献

1
Efficacy of Brucella abortus S19 and RB51 vaccine strains: A systematic review and meta-analysis.流产布鲁氏菌S19和RB51疫苗株的疗效:一项系统评价和荟萃分析。
Transbound Emerg Dis. 2022 Jul;69(4):e32-e51. doi: 10.1111/tbed.14259. Epub 2021 Aug 14.
2
A review of three decades of use of the cattle brucellosis rough vaccine Brucella abortus RB51: myths and facts.牛布鲁氏菌粗糙疫苗 Brucella abortus RB51 使用三十年的回顾:神话与事实。
BMC Vet Res. 2023 Oct 18;19(1):211. doi: 10.1186/s12917-023-03773-3.
3
Brucella abortus strain RB51 vaccination in elk. I. Efficacy of reduced dosage.麋鹿接种布鲁氏菌RB51疫苗。I. 减量剂量的效果。
J Wildl Dis. 2002 Jan;38(1):18-26. doi: 10.7589/0090-3558-38.1.18.
4
Efficacy of Brucella abortus vaccine strain RB51 compared to the reference vaccine Brucella abortus strain 19 in water buffalo.与参考疫苗布鲁氏菌流产菌株19相比,布鲁氏菌流产疫苗菌株RB51在水牛中的效力。
Vet Ital. 2010 Jan-Mar;46(1):13-9, 5-11.
5
Immune Response of Calves Vaccinated with Brucella abortus S19 or RB51 and Revaccinated with RB51.用布鲁氏菌流产亚种S19或RB51疫苗接种并再次用RB51疫苗接种的犊牛的免疫反应
PLoS One. 2015 Sep 9;10(9):e0136696. doi: 10.1371/journal.pone.0136696. eCollection 2015.
6
Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle.给牛接种商用流产布鲁氏菌RB51疫苗后的免疫反应和效果。
Vet Ther. 2000 Summer;1(3):183-91.
7
Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes.流产布鲁氏菌RB51菌株和马尔他布鲁氏菌Rev. 1活疫苗对妊娠母羊实验性感染马尔他布鲁氏菌的疗效比较。
Rev Sci Tech. 2001 Dec;20(3):741-7. doi: 10.20506/rst.20.3.1305.
8
Brucella abortus S19 and RB51 vaccine immunogenicity test: Evaluation of three mice (BALB/c, Swiss and CD-1) and two challenge strains (544 and 2308).布鲁氏菌流产亚种S19和RB51疫苗免疫原性试验:对三种小鼠(BALB/c、瑞士小鼠和CD-1)及两种攻击菌株(544和2308)进行评估。
Vaccine. 2015 Jan 15;33(4):507-11. doi: 10.1016/j.vaccine.2014.11.056. Epub 2014 Dec 9.
9
Survival of RB51 and S19 Vaccine Strains in Fresh and Ripened Cheeses.RB51 和 S19 疫苗株在新鲜和成熟奶酪中的存活情况。
Foodborne Pathog Dis. 2022 Aug;19(8):535-542. doi: 10.1089/fpd.2022.0001. Epub 2022 Jun 8.
10
Brucella abortus RB51 in milk of vaccinated adult cattle.接种疫苗的成年奶牛乳汁中的牛种布鲁氏菌RB51
Acta Trop. 2016 Aug;160:58-61. doi: 10.1016/j.actatropica.2016.04.012. Epub 2016 Apr 30.

引用本文的文献

1
Mapping the research landscape of immune response in human brucellosis: a bibliometric analysis.绘制人类布鲁氏菌病免疫反应的研究全景:一项文献计量分析。
Front Microbiol. 2025 Jul 29;16:1583520. doi: 10.3389/fmicb.2025.1583520. eCollection 2025.
2
Brucellosis in the omics era: integrative perspectives on Brucella genomic architecture, host-pathogen interactions, and disease dynamics.组学时代的布鲁氏菌病:关于布鲁氏菌基因组结构、宿主-病原体相互作用及疾病动态的综合观点
World J Microbiol Biotechnol. 2025 Jul 11;41(7):264. doi: 10.1007/s11274-025-04484-7.
3
Epidemiological assessment of bovine brucellosis in Iranian dairy farms: regional Seroprevalence and demographic indicators (2023-2024).
伊朗奶牛场牛布鲁氏菌病的流行病学评估:区域血清阳性率和人口统计学指标(2023 - 2024年)
Vet Res Commun. 2025 Jul 9;49(5):251. doi: 10.1007/s11259-025-10822-9.
4
Efficacy of Vaccines in Sheep: A Systematic Review and Meta-Analysis.绵羊疫苗的疗效:系统评价与荟萃分析
Transbound Emerg Dis. 2024 Jul 26;2024:5524768. doi: 10.1155/2024/5524768. eCollection 2024.
5
Role of RB51 vaccine in cow milk contamination of traditional milk sales centers.RB51疫苗在传统牛奶销售中心牛奶污染问题中的作用。
Trop Anim Health Prod. 2025 Mar 12;57(2):114. doi: 10.1007/s11250-025-04362-2.
6
Comparison of Long-Term Antibody Titers in Calves Treated with Different Conjunctival and Subcutaneous S19 Vaccines.不同结膜和皮下S19疫苗处理的犊牛长期抗体滴度比较
Animals (Basel). 2025 Jan 14;15(2):212. doi: 10.3390/ani15020212.
7
Fecal and vaginal microbiota of vaccinated and non-vaccinated pregnant elk challenged with .接种和未接种疫苗的怀孕麋鹿在受到……挑战后的粪便和阴道微生物群
Front Vet Sci. 2024 Jan 30;11:1334858. doi: 10.3389/fvets.2024.1334858. eCollection 2024.
8
Immune Responses Potentially Involved in the Gestational Complications of Infection.可能参与感染性妊娠并发症的免疫反应。
Pathogens. 2023 Dec 14;12(12):1450. doi: 10.3390/pathogens12121450.
9
Comparison of diagnostic tests for detecting bovine brucellosis in animals vaccinated with S19 and RB51 strain vaccines.对用S19和RB51菌株疫苗接种的动物进行牛布鲁氏菌病检测的诊断试验比较。
Vet World. 2023 Oct;16(10):2080-2085. doi: 10.14202/vetworld.2023.2080-2085. Epub 2023 Oct 14.
10
Brucellae as resilient intracellular pathogens: epidemiology, host-pathogen interaction, recent genomics and proteomics approaches, and future perspectives.布鲁氏菌作为顽强的细胞内病原体:流行病学、宿主-病原体相互作用、近期的基因组学和蛋白质组学方法以及未来展望。
Front Vet Sci. 2023 Oct 9;10:1255239. doi: 10.3389/fvets.2023.1255239. eCollection 2023.